State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
https://orcid.org/0000-0003-3319-4051.
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):25. doi: 10.1167/iovs.64.11.25.
The purpose of this study was to investigate choroidal vein (ChV) morphological features in pachychoroid disease (PCD) with choroidal vascular hyperpermeability (CVH).
This retrospective study assessed subfoveal choroidal thickness (SFCT) and CVH area numbers and locations of recruited patients with PCD using multimodal images. ChV alteration patterns, including fusiform, bulbosity, sausaging, confluence, and anastomoses, as well as asymmetric ChVs, dominant ChVs, and non-dominant ChVs, were evaluated using wide-field indocyanine green angiograms.
Of 68 PCD eyes from 35 patients (mean age: 46.16 ± 6.28 years, 71.4% men), 2.9% had uncomplicated pachychoroid, 32.4% had pachychoroid pigment epitheliopathy (PPE), 55.9% central serous chorioretinopathy (CSC), and 8.8% pachychoroid neovasculopathy (PNV). Mean SFCT was 468.65 ± 131.40 µm. Among 419 CVH areas, ChV fusiform, ChV bulbosity, and ChV sausaging accounted for 35.8%, 35.1%, and 29.1%, respectively; 21.2% had ChV confluence and 11.9% had ChV anastomoses. At CVH areas, 13.1% had retinal pigment epithelium (RPE) leakage. ChV fusiform is steadily declining (37.4%, 36.8%, and 22.9%, respectively), and ChV sausaging, ChV anastomoses, and ChV confluence are increased gradually in the PPE, CSC, and PNV groups (21.4%, 30.0%, and 37.1%; 11.4%, 11.1%, and 20.0%; and 19.8%, 20.9%, and 28.6%, respectively). Dominant ChVs had higher CVH area numbers than non-dominant ChVs in the PPE and CSC groups (P = 0.010, P = 0.001).
Different patterns of ChV alterations, including the newly identified ChV confluence, are commonly present at CVH areas in PCD. The CVH areas in PCD eyes are primarily located within the dominant ChVs. These findings provide crucial evidence for advancing our understanding of the underlying mechanisms of PCD pathogenesis.
本研究旨在探讨伴有脉络膜血管高通透性(CVH)的肥厚性脉络膜病变(PCD)中的脉络膜静脉(ChV)形态特征。
本回顾性研究使用多模态图像评估了 68 只 PCD 眼(35 名患者,平均年龄:46.16±6.28 岁,71.4%为男性)的中心凹下脉络膜厚度(SFCT)和 CVH 区域数量以及位置。使用广角吲哚菁绿血管造影评估 ChV 改变模式,包括梭形、球囊状、腊肠状、汇合和吻合,以及不对称 ChV、优势 ChV 和非优势 ChV。
2.9%为单纯性肥厚性脉络膜,32.4%为肥厚性脉络膜色素上皮病变(PPE),55.9%为中心性浆液性脉络膜视网膜病变(CSC),8.8%为肥厚性脉络膜新生血管病变(PNV)。平均 SFCT 为 468.65±131.40μm。在 419 个 CVH 区域中,ChV 梭形、ChV 球囊状和 ChV 腊肠状分别占 35.8%、35.1%和 29.1%;21.2%有 ChV 汇合,11.9%有 ChV 吻合。在 CVH 区域中,有 13.1%的视网膜色素上皮(RPE)渗漏。ChV 梭形逐渐减少(分别为 37.4%、36.8%和 22.9%),ChV 腊肠状、ChV 吻合和 ChV 汇合在 PPE、CSC 和 PNV 组中逐渐增加(分别为 21.4%、30.0%和 37.1%;11.4%、11.1%和 20.0%;19.8%、20.9%和 28.6%)。在 PPE 和 CSC 组中,优势 ChV 的 CVH 区域数量高于非优势 ChV(P=0.010,P=0.001)。
在 PCD 的 CVH 区域中,常见不同类型的 ChV 改变模式,包括新发现的 ChV 汇合。PCD 眼的 CVH 区域主要位于优势 ChV 内。这些发现为深入了解 PCD 发病机制提供了重要依据。